Safety of CoronaVac and ChAdOx1 vaccines against SARS-CoV-2 in patients with rheumatoid arthritis: data from the Brazilian multicentric study safer.
Cruz VA, Guimarães C, Rêgo J, Machado KLLL, Miyamoto ST, Burian APN, Dias LH, Pretti FZ, Batista DCFA, Mill JG, de Oliveira YGP, Gadelha CSE, da Penha Gomes Gouveia M, Moulin ACS, Souza BO, Aguiar LGR, Vieira GSS, Grillo LL, de Lima MD, Pasti LP, Surlo HF, Faé F, Moulaz IR, Macabú MO, Ribeiro PDC, Magalhães VO, de Aguiar MF, Biegelmeyer E, Peixoto FMMMC, Kayser C, de Souza AWS, de Moura Castro CH, Ribeiro SLE, Telles CMPF, Bühring J, de Lima RL, Dos Santos SHO, Dias SEB, de Melo NS, da Silva Sanches RH, Boechat AL, Sartori NS, Hax V, Dória LD, de Rezende RPV, Baptista KL, Fortes NRQ, de Melo AKG, Melo TS, de Abreu Vieira RMR, Vieira ASR, Kakehasi AM, Tavares ACFMG, de Landa AT, da Costa PVT, Azevedo VF, Martins-Filho OA, Peruhype-Magalhães V, de Medeiros Pinheiro M, Monticielo OA, Dos Reis-Neto ET, Ferreira GA, de Souza VA, Teixeira-Carvalho A, Xavier RM, Sato EI, Valim V, Pileggi GS, da Silva NA.
Cruz VA, et al. Among authors: vieira gss.
Adv Rheumatol. 2024 Aug 12;64(1):58. doi: 10.1186/s42358-024-00397-5.
Adv Rheumatol. 2024.
PMID: 39135131
Clinical Trial.
